BioXcel Therapeutics Inc (BTAI)
0.3384
+0.02
(+7.29%)
USD |
NASDAQ |
Dec 20, 16:00
0.3374
0.00 (0.00%)
Pre-Market: 20:00
BioXcel Therapeutics Shareholders Equity (Quarterly): -85.63M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 1.072M |
| Palatin Technologies Inc | -7.686M |
| iBio Inc | 17.75M |
| Theriva Biologics Inc | 24.64M |
| Oragenics Inc | 3.078M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 48.89M |
| Total Liabilities (Quarterly) | 134.52M |
| Debt to Equity Ratio | -1.220 |
| Current Ratio | 1.87 |
| Net Debt Paydown Yield | -5.86% |